GlaxoSmithKline PLC Director/PDMR Shareholding (8809L)
04 Mayo 2020 - 12:00PM
UK Regulatory
TIDMGSK
RNS Number : 8809L
GlaxoSmithKline PLC
04 May 2020
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Sir Jonathan Symonds
==== ======================================== =================================================
b) Position/status Non-Executive Chairman
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 January 2020 to 31 March
2020
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP16.93 2,584.170
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-04-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr Vindi Banga
==== ======================================== =================================================
b) Position/status Senior Independent Non-Executive Director
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 January 2020 to 31 March
2020
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP16.93 646.043
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-04-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Dr Vivienne Cox
==== ======================================== =================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 January 2020 to 31 March
2020
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP16.93 461.459
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-04-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Lynn Elsenhans
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 January 2020 to 31 March 2020
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$42.41 717.329
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-04-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Laurie Glimcher
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 January 2020 to 31 March 2020
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$42.41 1,176.571
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-04-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Dr Jesse Goodman
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 January 2020 to 31 March 2020
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$42.41 370.051
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-04-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===============================================================================================
a) Name Ms Judy Lewent
==== ======================================== =====================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===============================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===============================================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
==== ======================================== =====================================================
b) Nature of the Acquisition of notional ADSs under the
transaction share allocation arrangements for Non-Executive
Directors for the period of service from
1 January 2020 to 31 March 2020
==== ======================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ======================= =========================
$42.41 389.027
======================= =========================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
========================================= =========================================================
e) Date of the transaction 2020-04-29
==== ======================================== =====================================================
f) Place of the N/A
transaction
==== ======================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ===========================================================================================
a) Name Mr Urs Rohner
==== ======================================== =================================================
b) Position/status Independent Non-Executive Director
==== ======================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ======================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ===========================================================================================
a) Name GlaxoSmithKline plc
==== ======================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ======================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ===========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB0009252882
==== ======================================== =================================================
b) Nature of the Acquisition of notional Ordinary Shares
transaction under the share allocation arrangements
for Non-Executive Directors for the period
of service from 1 January 2020 to 31 March
2020
==== ======================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ======================================== ===================== =======================
GBP16.93 609.126
=================================================================== =======================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================ ==============================
e) Date of the transaction 2020-04-29
==== ======================================== =================================================
f) Place of the N/A
transaction
==== ======================================== =================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHQZLFBBELEBBD
(END) Dow Jones Newswires
May 04, 2020 13:00 ET (17:00 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024